Finance

Lists
Why is AGL up 6.46%?
Dive Deeper
AGL:NYSE
Agilon Health Inc
$80.73
+6.46%
(+4.90) 1D
$79.16
-1.94% (-1.57)
After hours
Closed: Sep 25, 4:00:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AGL...
Open
$76.65
High
$84.34
Low
$76.65
Mkt. cap
1.36B
Avg. vol.
219.80K
Volume
283.75K
52-wk high
$133.04
52-wk low
$7.48
EPS
-$14.06
Beta
3.02
Shares outstanding
16.79M
No. of employees
856
Open
$76.65
High
$84.34
Low
$76.65
Mkt. cap
1.36B
Avg. vol.
219.80K
Volume
283.75K
52-wk high
$133.04
52-wk low
$7.48
EPS
-$14.06
Beta
3.02
Shares outstanding
16.79M
No. of employees
856
News stories
From web sources and news partners
About Agilon Health Inc
CEOSteven Sell
Employees856
Founded2016
HeadquartersWesterville, Ohio, United States
SectorHealth care provider
Websiteagilonhealth.com
Analyst ratings
Based on 12 analysts giving stock ratings to AGL in the past 3 months
Hold
Buy
3
Hold
8
Sell
1
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for AGL in the last 3 months.
Highest
Current $80.73
$146.00 (+80.85%)
Average
$117.56 (+45.62%)
Lowest
$85.00 (+5.29%)
Analyst
Recommendation
Action
Price target
Projected
Date
Lance Wilkes
Bernstein
Buy
Upgraded
$125.00
+54.8%
09/15/2026
Lisa Gill
J.P. Morgan
Sell
Maintained
$85.00
+5.3%
08/24/2026
Jailendra Singh
Truist Financial
Hold
Maintained
-
-
08/24/2026
Stephen Baxter
Wells Fargo
Buy
Maintained
$146.00
+80.8%
08/10/2026
Daniel Grosslight
Citi
Hold
Upgraded
$115.00
+42.5%
08/11/2026
Ryan Langston
TD Cowen
Hold
Maintained
$95.00
+17.7%
08/07/2026
Michael Ha
Robert W. Baird
Hold
Maintained
$116.00
+43.7%
08/06/2026
Bill Sutherland
StoneX
Buy
Maintained
$140.00
+73.4%
08/06/2026
Elizabeth Anderson CFA
Evercore ISI
Hold
Maintained
$125.00
+54.8%
08/06/2026
Matthew Shea
Needham
Hold
Reiterated
-
-
08/06/2026
Andrew Mok CFA
Barclays
Hold
Maintained
$111.00
+37.5%
08/06/2026
Ryan Daniels
William Blair
Hold
Maintained
-
-
08/05/2026
Gary Taylor
TD Cowen
Hold
Reiterated
$55.00
-31.9%
05/11/2026
Jack Slevin
Jefferies
Buy
Upgraded
$48.00
-40.5%
05/07/2026
George Hill
Deutsche Bank
Buy
Upgraded
$49.00
-39.3%
05/07/2026
Michael Craig Jones
Bank of America Securities
Sell
Reiterated
$22.00
-72.7%
05/07/2026
Gordon Ramsay CFA
RBC Capital
Buy
Maintained
-
-
02/08/2026
Last report
Aug 5, 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
$2.15 / $0.27
+691.47%beat
Revenue / Est. (USD)
1.49B / 1.45B
+3.20%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.44B
1.57B
1.42B
1.49B
Cost of goods sold
1.50B
1.66B
1.36B
1.39B
Cost of revenue
1.50B
1.66B
1.36B
1.39B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
52.11M
58.76M
48.12M
80.87M
Operating expense
59.54M
65.73M
54.90M
87.73M
Total operating expenses
1.56B
1.73B
1.41B
1.48B
Operating income
-127.18M
-156.40M
10.11M
19.41M
Other non operating income
5.64M
38.04M
13.22M
12.52M
EBT including unusual items
-110.54M
-187.56M
29.94M
17.58M
EBT excluding unusual items
-106.45M
-150.13M
36.06M
25.22M
Income tax expense
-331.00K
1.32M
28.00K
-375.00K
Effective tax rate
0.30%
-0.71%
0.09%
-2.13%
Other operating expenses
-
-
-
-
Net income
-110.21M
-188.88M
48.92M
17.96M
Net profit margin
-7.68%
-12.03%
3.44%
1.20%
Earnings per share
-6.40
-8.95
2.32
2.15
Interest and investment income
3.80M
3.00M
2.80M
2.50M
Interest expense
-1.84M
-1.72M
-1.81M
-1.61M
Net interest expenses
1.96M
1.28M
989.00K
892.00K
Depreciation and amortization charges
7.43M
6.97M
6.79M
6.86M
EBITDA
-119.75M
-152.68M
16.90M
26.27M
Gain or loss from assets sale
-
-14.00M
-
-19.00M
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps